Medcura, Inc. — Form D

Medcura, Inc. of RIVERDALE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-28. The offering totals $5.0M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (13)

NameRoleLocation
Alex ArrowDirectorRiverdale, MD
Jim BuckDirectorLakewood, WA
Jim BuckExecutive OfficerLakewood, WA
Rich VincentExecutive OfficerRiverdale, MD
Larry TiffanyDirectorRiverdale, MD
Larry TiffanyExecutive OfficerRiverdale, MD
Abbas Ardehali, M.D.DirectorRiverdale, MD
Matthew Dowling, Ph.DDirectorRiverdale, MD
Matthew Dowling, Ph.DExecutive OfficerRiverdale, MD
Matthew DowlingDirectorRiverdale, MD
Matthew DowlingExecutive OfficerRiverdale, MD
Peter ThomasDirectorColumbus, OH
Peter ThomasExecutive OfficerColumbus, OH

Other filings by this issuer (8)

FiledFormOfferingSold
2025-07-25D$38.3M$28.5M
2024-07-24D/A$22.8M$22.5M
2022-08-16D$5.6M$3.2M
2021-11-02D$5.8M$3.5M
2018-07-02D$2.5M$1.6M
2016-11-10D/A$3.1M$1.1M
2016-09-20D$3.1M$93K
2016-04-14D$200$11

More